Pricing Supplement dated March 6, 1995                           Rule 424(b)(3)
(To Prospectus dated January 8, 1993 and                      File No. 33-54870
Prospectus Supplement dated February 15, 1995)

                         NATIONWIDE HEALTH PROPERTIES, INC.
                            Medium-Term Note - Fixed Rate
_________________________________________________________________

Face Amount: $ 15,000,000
Trade Date: March 3, 1995
Issue Price: 100%
Original Issue Date: March 10, 1995
Interest Rate: 8.67%
Net Proceeds to Issuer:$ 14,906,250
Interest Payment Dates: April 1, October 1
Agent's Commission: .625%
Regular Record Dates: March 17, September 16
Name of Agent: Merrill Lynch
Stated Maturity Date: March 10, 2005
Agent acting in the capacity indicated below:
 [X] As Agent
 [ ] As Principal
Denominations (if other than $1000 and integral multiples
thereof):_______________
_________________________________________________________________

Day Count Convention:
 [X] 30/360 for the period from March 10, 1995 to March 10, 2005
 [ ] Actual/360 for the period from            to
 [ ] Actual/Actual for the period from         to
 [ ] Other (see attached)                      to

Redemption:
 [X] The Notes cannot be redeemed prior to the Stated Maturity
     Date.
 [ ] The Notes may be redeemed prior to Stated Maturity Date.
     Initial Redemption Date:
     Initial Redemption Percentage:     %
     Annual Redemption Percentage Reduction:      % until
     Redemption Percentage is 100% of the Principal Amount.

Repayment:
 [X] The Notes cannot be repaid prior to the Stated Maturity
     Date.
 [ ] The Notes can be repaid prior to the Stated Maturity Date at
     the option of the holder of the Notes.
     Optional Repayment Date(s):
     Repayment Price:      %

Original Issue Discount: [ ] Yes    [X] No
 Total Amount of OID:
 Yield to Maturity:
 Initial Accrual Period:

Form: [X] Book-entry     [ ] Certificated
                       _______________________________________

Goldman, Sachs & Co.                  Merrill Lynch & Co.